/주식/KVUE
KVUE

KVUE

USD

Kenvue Inc. Common Stock

$23.010+0.130 (0.568%)

실시간 가격

Consumer Defensive
Household & Personal Products
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$22.880

고가

$23.455

저가

$22.385

거래량

2.63M

기업 기본 정보

시가총액

44.1B

산업

Household & Personal Products

국가

United States

거래 통계

평균 거래량

17.17M

거래소

NYQ

통화

USD

52주 범위

저가 $17.67현재가 $23.010고가 $24.46

AI 분석 리포트

마지막 업데이트: 2025년 4월 25일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

KVUE (Kenvue Inc. Common Stock): Checking the Pulse on Recent Activity & What Might Be Next

Stock Symbol: KVUE Generate Date: 2025-04-25 03:41:00

Let's break down what's been happening with Kenvue lately, looking at the news, how the stock price has moved, and what some automated tools are suggesting. Think of this as getting a quick rundown on the situation.

What's the Buzz? (News Sentiment)

Looking at the recent headlines, you get a bit of a mixed bag, but there are some positive notes in there.

First off, Kenvue is getting ready to spill the beans on their first quarter results on May 8th. That's a big date coming up – earnings calls can often shake things up, depending on whether the numbers beat expectations or fall short.

On the brighter side, the company just announced they're paying out a quarterly dividend of $0.205 per share. Getting cash back is usually seen as a good sign by investors. Plus, they've inked a five-year deal with Microsoft to boost their digital operations. That sounds like a move to become more efficient and modern, which is generally a positive step for a big consumer company. They also brought in actress Shay Mitchell as a global ambassador for their OGX haircare brand – a marketing push to hopefully sell more products.

Now, for the less sunny bits. One analyst over at Barclays trimmed their price target on the stock slightly, moving it from $23 down to $22 while keeping an "Equal-Weight" rating. Another firm, Redburn Atlantic, just started covering Kenvue and gave it a "Neutral" rating with a $23.50 target. So, the analyst community isn't exactly jumping up and down with excitement right now; they seem a bit cautious or neutral.

Overall, the news flow has some definite positives (dividend, Microsoft, marketing) mixed with a couple of neutral-to-slightly-negative analyst views and the big unknown of the upcoming earnings report.

Checking the Chart (Price Action)

If you look at the stock's movement over the past month or so, it's been a bit of a bumpy ride. After climbing towards the end of March and hitting a peak around $24, the price took a noticeable dip in early April. Since then, it's been trying to find its footing, trading mostly between $21.50 and $23.50.

The last recorded closing price was around $22.75. Compared to where it was a month ago (around $23.40), it's drifted lower overall, but it's also recovered a bit from the lows seen around April 7th ($21.77 close).

Interestingly, an AI prediction model is suggesting the price might tick up slightly today (around 0.44%) and continue gaining over the next couple of days (2.01% and 2.87% increases predicted). This contrasts a bit with the recent downward drift but aligns with the AI's overall bullish sentiment score.

Putting It Together: What Might This Mean?

Based on the mix of news, the recent price dip followed by a potential stabilization attempt, and the AI's forecast for near-term upward movement, the situation seems to lean cautiously positive for the very short term, if you trust the AI's technical and sentiment analysis.

The AI model, in fact, points to some technical signals suggesting bullish momentum, like certain indicators crossing over and a surge in trading volume recently that indicates strong buying interest. It also notes the positive news sentiment. However, it flags some fundamental concerns about the company itself, like revenue growth being slightly negative and higher-than-ideal debt levels.

So, what could someone watching this stock consider?

  • Potential Entry Consideration: The AI's prediction for upward movement over the next few days, combined with its technical analysis suggesting the price is near a support level (it mentioned $22.85, and the last close was $22.75, which is right there), might make the current price area look interesting for someone thinking about a short-term trade, if they believe the AI's forecast. The AI itself suggested entry points slightly higher ($22.91, $23.03), which could be levels to watch if the price starts moving up.
  • Potential Exit/Stop-Loss Consideration: To manage risk, the AI suggested a stop-loss level around $20.64. This is a potential point where someone might decide to sell to limit losses if the price drops unexpectedly. For potential gains, the AI pointed to a take-profit level around $24.22. This is a level where the price might hit resistance or where someone might consider selling to lock in profits.

Remember, these are just potential ideas based on the data and the AI's interpretation. The upcoming earnings report is a wild card that could significantly change the picture.

A Little Company Context

Just to keep in mind, Kenvue is the company behind a ton of everyday products you probably know – Tylenol, Neutrogena, Listerine, Johnson's Baby, Band-Aid, and more. They operate in the consumer health space. This means their business is generally considered more stable than, say, a tech startup, but they still face challenges like competition, marketing costs (like that new brand ambassador!), and keeping up with consumer trends. They're a big company, valued at over $43 billion.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

Reuters

Loeb's Third Point builds stake in Band-Aid maker Kenvue

Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter said on Friday, as some investors are pushing for strategic changes at the consumer healthcare company.

더 보기
Loeb's Third Point builds stake in Band-Aid maker Kenvue
BusinessWire

Kenvue to Announce First Quarter 2025 Results on May 8, 2025

Kenvue Inc. (NYSE:KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial

더 보기
Kenvue to Announce First Quarter 2025 Results on May 8, 2025
BusinessWire

Kenvue Declares Quarterly Cash Dividend

Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on its common stock. This quarterly dividend is payable on May 28, 2025, to shareholders of

더 보기
Kenvue Declares Quarterly Cash Dividend
BusinessWire

Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundation

더 보기
Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations
Analyst Upgrades

Barclays Maintains Equal-Weight on Kenvue, Lowers Price Target to $22

Barclays analyst Lauren Lieberman maintains Kenvue with a Equal-Weight and lowers the price target from $23 to $22.

더 보기
Barclays Maintains Equal-Weight on Kenvue, Lowers Price Target to $22
Analyst Upgrades

Redburn Atlantic Initiates Coverage On Kenvue with Neutral Rating, Announces Price Target of $23.5

Redburn Atlantic analyst Edward Lewis initiates coverage on Kenvue with a Neutral rating and announces Price Target of $23.5.

PR Newswire

OGX® Haircare Introduces Shay Mitchell as First Global Brand Ambassador

Kenvue Inc. (NYSE: KVUE) announces actress and entrepreneur, Shay Mitchell, as the global brand ambassador for OGX®, stepping in as the face of the...

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 4월 28일 오전 03:09

약세중립강세

64.8% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보수적
트레이딩 가이드

진입점

$23.14

익절

$23.47

손절

$20.71

핵심 요소

PDI 10.6이(가) ADX 19.8과 함께 MDI 9.3 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($23.09)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(175,870)의 7.5배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.0619이(가) 신호선 0.0815 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기